Pfizer/BioNTech Covid-19 vaccine shows 90.7% efficacy in trial in children
More than twice as many children in the 2,268-participant trial were given the vaccine than placebo, that equates to better than 90% efficacy
More than twice as many children in the 2,268-participant trial were given the vaccine than placebo, that equates to better than 90% efficacy